Bolt Biotherapeutics, Inc. (BOLT) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-05-16
4:31 pm
Sale
2022-05-1613GBOLT BIOTHERAPEUTICS, INC
BOLT
RA Capital Management, L.P.0
0.000%
-118,916decrease
(Position Closed)
Filing
History
2022-02-14
06:12 am
Sale
2021-12-3113GBOLT BIOTHERAPEUTICS, INC
BOLT
Citadel Advisors LLC140,622
7.500%
-6,478decrease
(-4.40%)
Filing
History
2021-11-29
4:39 pm
Purchase
2021-11-1813GBOLT BIOTHERAPEUTICS, INC
BOLT
Montanova Capital, LLC111,513
6.000%
111,513increase
(New Position)
Filing
History
2021-11-22
4:03 pm
Unchanged
2021-11-1513DBOLT BIOTHERAPEUTICS, INC
BOLT
Novo Holdings A/S225,200
12.000%
0
(Unchanged)
Filing
History
Goto Prev, 0, 1